These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 24288089)

  • 1. Structure based antibody-like peptidomimetics.
    Murali R; Greene MI
    Pharmaceuticals (Basel); 2012 Feb; 5(2):209-35. PubMed ID: 24288089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full-length recombinant antibodies from
    Rashid MH
    MAbs; 2022; 14(1):2111748. PubMed ID: 36018829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal Antibodies and Antibody Like Fragments Derived from Immunised Phage Display Libraries.
    Ubah O; Palliyil S
    Adv Exp Med Biol; 2017; 1053():99-117. PubMed ID: 29549637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedical Applications of a Novel Class of High-Affinity Peptides.
    Saw PE; Xu X; Kim S; Jon S
    Acc Chem Res; 2021 Sep; 54(18):3576-3592. PubMed ID: 34406761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shark variable new antigen receptor biologics - a novel technology platform for therapeutic drug development.
    Kovaleva M; Ferguson L; Steven J; Porter A; Barelle C
    Expert Opin Biol Ther; 2014 Oct; 14(10):1527-39. PubMed ID: 25090369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The identification of affinity peptide ligands specific to the variable region of human antibodies.
    Akiyama Y; Miyata H; Komiyama M; Nogami M; Ozawa K; Oshita C; Kume A; Ashizawa T; Sakura N; Mochizuki T; Yamaguchi K
    Biomed Res; 2014; 35(2):105-16. PubMed ID: 24759178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer.
    Alati S; Singh R; Pomper MG; Rowe SP; Banerjee SR
    Semin Nucl Med; 2023 Sep; 53(5):663-686. PubMed ID: 37468417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light-chain shuffling results in successful phage display selection of functional prokaryotic-expressed antibody fragments to N-glycolyl GM3 ganglioside.
    Rojas G; Talavera A; Munoz Y; Rengifo E; Krengel U; Angström J; Gavilondo J; Moreno E
    J Immunol Methods; 2004 Oct; 293(1-2):71-83. PubMed ID: 15541278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody like peptidomimetics as large scale immunodetection probes.
    Murali R; Liu Q; Cheng X; Berezov A; Richter M; Furuchi K; Greene MI; Zhang H
    Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):209-16. PubMed ID: 12887103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
    Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
    MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of human antibodies against the C5aR target using phage display technology.
    Huang L; Sato AK; Sachdeva M; Fleming T; Townsend S; Dransfield DT
    J Mol Recognit; 2005; 18(4):327-33. PubMed ID: 15706605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity for the cognate monoclonal antibody of synthetic peptides derived from selection by phage display. Role of sequences flanking thebinding motif.
    Ferrières G; Villard S; Pugnière M; Mani JC; Navarro-Teulon I; Rharbaoui F; Laune D; Loret E; Pau B; Granier C
    Eur J Biochem; 2000 Mar; 267(6):1819-29. PubMed ID: 10712615
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.